CN Stock MarketDetailed Quotes

300294 China Resources Boya Bio-pharmaceutical Group

Watchlist

36.30
+3.40+10.33%

Market Closed Sep 30 15:00 CST

18.30BMarket Cap80.49P/E (TTM)

China Resources Boya Bio-pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

China Resources Boya Bio-pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 531.000M	--
--	2024/Q3	-- / 512.000M	--
--	2024/Q2	447.283M / 417.000M	--
--	2024/Q1	448.453M / 629.000M	--
--	2023/Q4	461.581M / 430.000M	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 531.000M--

--2024/Q3-- / 512.000M--

--2024/Q2447.283M / 417.000M--

--2024/Q1448.453M / 629.000M--

--2023/Q4461.581M / 430.000M--

Unlock Free Earnings Estimates

Open Account

China Resources Boya Bio-pharmaceutical Group Earnings Reports

China Resources Boya Bio-pharmaceutical Group: Summary of Half-Year Report in 2024.

Aug 23 12:00 ET

China Resources Boya Bio-pharmaceutical Group: Half-year report for the year 2024.

Aug 23 12:00 ET

Liberal Arts Biotech: Report for the first quarter of 2024

Apr 23 12:00 ET

Liberal Arts Biotech: 2023 Annual Report Summary

Mar 22 12:00 ET

Analyst Rating

Updated: Oct 5, 2024

Strong Buy

Strong Buy
100.00%
Buy
0.00%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall